Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference [Yahoo! Finance]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Yahoo! Finance
a leaner operating profile and a near-term set of clinical and regulatory milestones expected over the coming months. Speaking at a J.P. Morgan-hosted event, Payne described Arcturus as an mRNA medicines company founded in 2013 and based in San Diego. He said the broader biotech downturn has led Arcturus to become “much leaner and more focused,” with approximately 100 employees and a strategy centered on what he characterized as “value-creating assets.” ? NVIDIA's Next Leg Higher May Have Started at CES Payne noted that Arcturus has a COVID-19 vaccine, Kostaive, approved in more than 30 countries, including Japan, the United Kingdom, and the European Union. He said the product is partnered with CSL and distributed in Japan by Meiji. Payne also highlighted U.S. government support for an H5N1 pandemic influenza program through BARDA. However, he said the remainder of his remarks would focus on Arcturus-owned therapeutic candidates rather than partnered vaccine programs. ? Mark
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- G7, other allies discuss ways to reduce dependence on Chinese rare earths [Yahoo! Finance Canada]Yahoo! Finance Canada
- Why JPMorgan now sees zero rate cuts in 2026 — and a hike coming the following year [Yahoo! Finance]Yahoo! Finance
- Appetite for weight-loss deals broader than visible, Viking CEO says [Yahoo! Finance]Yahoo! Finance
- JPMorgan earnings, December CPI, Trump comments: What to Watch [Yahoo! Finance]Yahoo! Finance
- Stock market today: Dow, S&P 500, Nasdaq futures steady after Fed drama as CPI inflation check looms [Yahoo! Finance Canada]Yahoo! Finance Canada
JPM
Earnings
- 10/14/25 - Beat
JPM
Sec Filings
- 1/12/26 - Form 424B2
- 1/12/26 - Form 424B2
- 1/12/26 - Form 424B2
- JPM's page on the SEC website